CD274 and non-small cell lung carcinoma: In the present study, we investigated whether GDF15 levels can be a predictive marker in patients with NSCLC treated with PD-1/PD-L1 inhibitors and identified the association between circulating GDF15 levels and immune cell populations of peripheral blood mononuclear cells (PBMCs).